Daiichi Life Group's New Zealand insurance arm, Partners Life, has agreed to pay NZ$630mn, about ¥59.6bn at the disclosed exchange rate of NZ$1 to ¥94.65, for all of Fidelity Life Assurance Company Limited, an Auckland-based life insurer founded in 1973. Partners Life decided on September 3, 2026 to sign the share purchase agreement, and Daiichi filed a matching extraordinary report with Japan's Kanto Local Finance Bureau the same day.
The sellers are not a single founder or private equity fund. Guardians of New Zealand Superannuation, the state pension manager, holds 49.62% of Fidelity Life; Ngāi Tahu Investments Limited, tied to the South Island iwi, holds 24.93%; the Fidelity Family Account holds 14.64%; and other shareholders split the remaining 10.81%. All of it goes to Partners Life, taking Daiichi's indirect stake in Fidelity Life from zero to 4,492,670 shares, or 100% of the voting rights.
| Item | Detail |
|---|---|
| Purchase price | NZ$630 million (about ¥59.6bn at NZ$1 = ¥94.65) |
| Shares acquired | 4,492,670 shares, 100% of voting rights, held indirectly |
| Key sellers | Guardians of New Zealand Superannuation (49.62%), Ngāi Tahu Investments Limited (24.93%), Fidelity Family Account (14.64%), other holders (10.81%) |
| Deal structure | Dai-ichi's intermediate holding company injects capital into Partners Life, which then buys all of Fidelity Life's shares |
| Expected closing | March to July 2027, subject to regulatory approval |
| Specified-subsidiary trigger | Fidelity Life's capital exceeds 10% of Dai-ichi's own capital, requiring an extraordinary disclosure report |
The mechanics matter for anyone tracking Daiichi's balance sheet: its intermediate holding company will inject fresh capital into Partners Life, which then uses that capital to buy Fidelity Life outright, rather than Daiichi funding the purchase directly from Tokyo. Because Fidelity Life's own capital, NZ$376mn as of the end of June 2026, exceeds one-tenth of Daiichi's capital, the target automatically becomes what Japanese securities law calls a specified subsidiary, which is why the deal required an extraordinary report rather than routine disclosure.
Fidelity Life is not a small add-on. In the year to June 2025 it generated NZ$459mn in insurance revenue and NZ$14mn in net profit, on net assets of NZ$221mn and total assets of NZ$758mn. Partners Life itself, which Daiichi fully absorbed in November 2022, reported NZ$615mn in insurance revenue and NZ$35mn in net profit for the year to March 2026. The two insurers sell through different channels: Partners Life leans on a digital platform serving independent financial advisers, while Fidelity Life is stronger in suburban and regional adviser networks and group insurance.
Daiichi frames the purchase as part of a push to lift overseas life insurance to roughly half of group adjusted profit by the year to March 2031, and expects Fidelity Life to add about NZ$60mn (roughly ¥5.7bn) a year to that profit measure at the earliest during its next medium-term plan. None of that arrives soon. Closing is scheduled for March to July 2027 in New Zealand, contingent on approval from local regulators, and Daiichi says it is still assessing the effect on this year's and next year's consolidated results.